India eyes $40 billion global generic market

In a first-of-its-kind initiative, India has launched a sustained global campaign to capture an estimated $40 billion worth of additional market for generic or copied medicines as patents held by multinationals on sophisticated medicines run out over the next three years. While emphasis is on countries with ageing population such as Japan, which needs more of cheaper medicine, large markets such as Africa and Latin America are also in focus.

Read Full Story>>